ILLUMINA, INC. ILMN revenue by segment, product and geography
In its fiscal year ending 2025-12-31, ILLUMINA, INC. reported revenue across 2 business segments; the largest, Sequencing, was $3.98B, 91.8% of the filed sum (-0.2% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Sequencing$3.98B91.8%-0.2% yoy
- Microarray$358M8.2%-5.5% yoy
Members sum to the consolidated $4.34B for this period.
- Product$3.71Bshare n/a+1.4% yoy
- Consumables$3.23Bshare n/a+2.3% yoy
- Service$634Mshare n/a-11.5% yoy
- Instruments$482Mshare n/a-3.8% yoy
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- Americas$2.41Bshare n/a-1.4% yoy
- United States$2.24Bshare n/a-2.0% yoy
- Europe$1.26Bshare n/a+6.7% yoy
- Asia Pacific Middle East And Africa$430Mshare n/a-1.8% yoy
- China$243Mshare n/a-21.1% yoy
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- Sequencing$1.05B90.9%no prior
- Microarray$105M9.1%no prior
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.